Prognostic value of circulating microRNA-21 for breast cancer: a systematic review and meta-analysis

References

• Abdel-Hamid NR, Mohammed EA, Abbas AH, Badr FM. 2015. MicroRNA-21 expression in primary breast cancer tissue among egyptian female patients and its correlation with chromosome 17 aneusomy. Mol Diagn Ther. 19:365–373.
   PubMed Web of Science ®Google Scholar
• Chen H, Liu H, Zou H, Chen R, Dou Y, Sheng S, et al. 2016. Evaluation of plasma miR-21 and miR-152 as diagnostic biomarkers for common types of human cancers. J Cancer. 7:490–499.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang X. 2014. MicroRNA-21 in breast cancer: diagnostic and prognostic potential. Clin Transl Oncol. 16:225–233.
   PubMed Web of Science ®Google Scholar
• De Mattos-Arruda L, Bottai G, Nuciforo PG, Di Tommaso L, Giovannetti E, Peg V, et al. 2015. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 6:37269–37280.
   PubMed Web of Science ®Google Scholar
• Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. 2008. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 283:1026–1033.
   PubMed Web of Science ®Google Scholar
• Gao Y, Cai Q, Huang Y, Li S, Yang H, Sun L, Chen K, Wang Y. 2016. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies. Oncotarget. 7:34498–34506.
   PubMed Web of Science ®Google Scholar
• Hafez MM, Hassan ZK, Zekri AR, Gaber AA, Al Rejaie SS, Sayed-Ahmed MM, Al Shabanah O. 2012. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac J Cancer Prev. 13:591–598.
   PubMed Web of Science ®Google Scholar
• Hemmatzadeh M, Mohammadi H, Jadidi-Niaragh F, Asghari F, Yousefi M. 2016. The role of oncomirs in the pathogenesis and treatment of breast cancer. Biomed Pharmacother. 78:129–139. Epub 2016/02/24.
   PubMed Web of Science ®Google Scholar
• Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Shen X, You J, Hu XQ. 2009. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep. 21:673–679.
   PubMed Web of Science ®Google Scholar
• Ivan C, Grazia CM, Ada D, Pietro R, Saveria A, Paola A, et al. 2016. Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor. Oncotarget. 7:12651–12661.
   PubMed Web of Science ®Google Scholar
• Kumar S, Keerthana R, Pazhanimuthu A, Perumal P. 2013. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients. Indian J Biochem Biophys. 50:210–214.
   PubMed Web of Science ®Google Scholar
• Lee JA, Lee HY, Lee ES, Kim I, Bae JW. 2011. Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast. J Breast Cancer. 14:269–275.
   PubMed Web of Science ®Google Scholar
• Li S, Yang X, Yang J, Zhen J, Zhang D. 2016. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis. Clin Exp Med. 16:29–35.
   PubMed Web of Science ®Google Scholar
• Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y. 2008. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 27:4373–4379.
   PubMed Web of Science ®Google Scholar
• Marino AL, Evangelista AF, Vieira RA, Macedo T, Kerr LM, Abrahao-Machado LF, et al. 2014. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study. BMC Cancer. 14:739.
   PubMed Web of Science ®Google Scholar
• Markou A, Yousef GM, Stathopoulos E, Georgoulias V, Lianidou E. 2014. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. Clin Chem. 60:197–205.
   PubMed Web of Science ®Google Scholar
• Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F. 2016. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women. Gene. 590:210–219.
   PubMed Web of Science ®Google Scholar
• Muller V, Gade S, Steinbach B, Loibl S, von Minckwitz G, Untch M, et al. 2014. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. Breast Cancer Res Treat. 147:61–68.
   PubMed Web of Science ®Google Scholar
• Ota D, Mimori K, Yokobori T, Iwatsuki M, Kataoka A, Masuda N, et al. 2011. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Int J Oncol. 38:955–962.
   PubMed Web of Science ®Google Scholar
• Ozgun A, Karagoz B, Bilgi O, Tuncel T, Baloglu H, Kandemir EG. 2013. MicroRNA-21 as an indicator of aggressive phenotype in breast cancer. Onkologie. 36:115–118.
   PubMedGoogle Scholar
• Pan F, Mao H, Deng L, Li G, Geng P. 2014. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis. Int J Clin Exp Pathol. 7:5622–5633. Epub 2014/10/23.
   PubMed Web of Science ®Google Scholar
• Petrovic N. 2016. miR-21 might be involved in breast cancer promotion and invasion rather than in initial events of breast cancer development. Mol Diagn Ther. 20:97–110.
   PubMed Web of Science ®Google Scholar
• Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H. 2009. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat. 117:131–140.
   PubMed Web of Science ®Google Scholar
• Rask L, Balslev E, Jorgensen S, Eriksen J, Flyger H, Moller S, et al. 2011. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 119:663–673.
   PubMed Web of Science ®Google Scholar
• Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, et al. 2010. Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med. 33:E124.
   PubMed Web of Science ®Google Scholar
• Sakurai M, Masuda M, Miki Y, Hirakawa H, Suzuki T, Sasano H. 2015. Correlation of miRNA expression profiling in surgical pathology materials, with Ki-67, HER2, ER and PR in breast cancer patients. Int J Biol Markers. 30:e190–e199.
   PubMed Web of Science ®Google Scholar
• Shen L, Wan Z, Ma Y, Wu L, Liu F, Zang H, Xin S. 2015. The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers. Tumour Biol. 36:1993–2005.
   PubMed Web of Science ®Google Scholar
• Stang A. 2010. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25:603–605.
   PubMed Web of Science ®Google Scholar
• Walter BA, Gomez-Macias G, Valera VA, Sobel M, Merino MJ. 2011. miR-21 expression in pregnancy-associated breast cancer: a possible marker of poor prognosis. J Cancer. 2:67–75.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang L, Sun S, Wu J, Wang Q. 2015. Quantitative measurement of serum microRNA-21 expression in relation to breast cancer metastasis in Chinese females. Ann Lab Med. 35:226–232.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Pan C, Ma F, Zhang S. 2015. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. PLoS One. 10:e0118647.
   PubMed Web of Science ®Google Scholar
• Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. 2008. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 14:2348–2360.
   PubMed Web of Science ®Google Scholar
• Yan LX, Liu YH, Xiang JW, Wu QN, Xu LB, Luo XL, et al. 2016. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol. 48:471–484. Epub 2015/12/18.
   PubMed Web of Science ®Google Scholar
• Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, et al. 2011. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res. 13:R2.
   PubMed Web of Science ®Google Scholar